UBA1 and viral infectious disease: Inhibition of proteasome-mediated protein degradation with MG132 potently inhibited viral infection, while inhibition of ubiquitin conjugation by PYR-41 (an E1 ubiquitin-activating enzyme inhibitor) displayed no effect.